Brimonidine Protects Retinal Neurons from Damage in Glaucoma
Author Information
Author(s): Wendi S Lambert, Lupe Ruiz, Samuel D Crish, Larry A Wheeler, David J Calkins
Primary Institution: The Vanderbilt Eye Institute, Vanderbilt University Medical Center
Hypothesis
Does brimonidine preserve retinal ganglion cell axonal transport and prevent degeneration in a rat model of elevated ocular pressure?
Conclusion
Brimonidine treatment significantly improved retinal ganglion cell survival and axonal transport in rats with elevated ocular pressure.
Supporting Evidence
- Brimonidine treatment prevented a 44% decrease in ganglion cell uptake of cholera toxin.
- There was a 33% loss of ganglion cell axons in vehicle-treated rats, which was prevented by brimonidine.
- Brimonidine improved axonal transport to the superior colliculus by 124% compared to vehicle treatment.
Takeaway
Brimonidine is a medicine that helps protect important eye cells from getting hurt when the pressure in the eye is too high.
Methodology
Rats were treated with brimonidine or a vehicle for 8 weeks after inducing elevated ocular pressure, and various measures of retinal ganglion cell health were assessed.
Limitations
The study was conducted in a rat model, which may not fully replicate human glaucoma.
Participant Demographics
Male Sprague-Dawley rats, weight range 350-400 g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website